Calithera Biosciences, Inc.
CALA
$0.0001
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 29.24% | -7.99% | 34.39% | 80.01% | -519.50% |
| Total Depreciation and Amortization | 4.84% | -3.13% | 0.00% | -1.54% | -5.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.89% | 271.75% | -167.24% | -96.66% | 1,432.42% |
| Change in Net Operating Assets | -954.60% | 125.59% | 65.49% | -4,548.19% | -87.42% |
| Cash from Operations | -11.14% | 31.32% | 29.64% | 37.39% | -236.25% |
| Capital Expenditure | -- | 100.00% | -- | -- | 63.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | 63.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.33% | -99.82% | 647.49% | 37.32% | 82,700.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -73.33% | -99.82% | 647.49% | 73.59% | 65,400.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.60% | -168.56% | 80.67% | 40.40% | -223.60% |